Tyra Biosciences Raises $126M in Block Sale of 4M Shares
TYRA has more than doubled off its 52-week low of $6.42 on elevated volume (8.1× avg).
Summary
Tyra Biosciences sold 4 million shares for $126 million to an investment firm, bolstering its cash position and extending its operational runway.
Key Events · Financing and Capital Events · TYRA
-
Capital Raise via Share Sale
Tyra Biosciences agreed to sell 4,000,000 shares of common stock to a large investment management firm.
-
Significant Gross Proceeds
The company expects to receive $126.0 million in gross proceeds from the sale, before deducting fees and expenses.
-
Offering Price and Program
Shares were sold at $31.50 each as a block transaction under the company's existing at-the-market (ATM) offering program, which was registered on May 8, 2025.
Analysis · TYRA · Life Sciences
Tyra Biosciences has secured a substantial capital infusion of $126 million through the sale of 4 million common shares to a large investment management firm. This transaction, executed as a block sale under an existing at-the-market program, provides significant additional funding. While the offering price of $31.50 per share represents a discount to the current market price, and the company is trading near its 52-week high, this capital raise strengthens the company's balance sheet and extends its cash runway, which was previously projected through at least 2027. This capital raise is a material event for a clinical-stage biotech company, providing resources for ongoing pipeline development.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TYRA was trading at $34.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $6.42 to $35.96. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.